Skip to content
healthcare.dev
Get a free key

Bisoprolol Fumarate and Hydrochlorothiazide

NDC 10135-742, Bisoprolol Fumarate and Hydrochlorothiazide, tablet, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-742
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215562
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-742 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISOPROLOL FUMARATE10 mg/1
  • HYDROCHLOROTHIAZIDE6.25 mg/1

Pharmacologic classes

Adrenergic beta-Antagonists [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]; beta-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
10135-742-0510135074205500 TABLET in 1 BOTTLE (10135-742-05)
10135-742-301013507423030 TABLET in 1 BOTTLE (10135-742-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/df881501-42ae-624a-e053-2995a90ab2a0

Use it

Look up 10135-742 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-742 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-742. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.